Clinical trials

174

Search and review clinical trials. Use filters to narrow results by trial status, phase, treatment, biological sex and sponsor.

Condition / disease
Location
Status: Not yet recruiting

BIG Chicago: A Trial of Basic Income Guarantee for Young People Living With HIV

The goal of this clinical trial is to compare two interventions - Basic Income Guarantee (BIG) + Treatment as Usual and Treatment as Usual among individuals living with HIV who have experienced financial hardships. The main question it aims to answer is: Compared with the Treatment as Usual group, will participants in the BIG + Treatment as Usual group be more likely to improve care engagement and viral suppression? Participants on the study will be: * Randomly assigned (like the flip of a coin) to participate in either BIG + Treatment as Usual or Treatment as Usual. Participants will have an equal chance of being placed in either group. * Complete 9 surveys over a 36 month period. * Complete a release of information so electronic medical record data can be accessed for the 18 months prior to treatment engagement and for 36 months from program enrollment. * Participants in the Treatment as Usual group will not receive any intervention. * HIV viral load testing will be confirmed at 3 timepoints (baseline, 12 months, and 18 months). * Participants in the BIG + Treatment as Usual group will receive $500 monthly income for 18 months. * Participants in the BIG + Treatment as Usual group will complete 3 social network surveys to assess how receiving BIG impacts their social networks. * A subset of participants in the BIG + Treatment as Usual group (30 participants) will complete 5 individual interviews over the course of receiving BIG and the 18 months after.

Participants needed: 304
Trial details
Age: 18-35Biological sex: AllType: InterventionalSponsor: University of ChicagoUpdated: Jul 13, 2026
Eligibility criteria

Living with HIV for 24 months or longer; [+6]

Unwilling/unable to provide informed consent [+2]

Status: Not yet recruiting

Outpatient Visits Versus Telehealth for Postoperative Care After Minimally Invasive Gynecologic Surgery

Telehealth, or telemedicine, utilizes technology to deliver clinical care remotely, either in real time or asynchronously, between clinician and patient. Telemedicine has been successfully implemented to increase healthcare delivery for patients in rural areas with otherwise long travel times, and studies have also determined that telemedicine can increase patient satisfaction scores while simultaneously decreasing direct and indirect costs for patients. Previous scholarship has demonstrated that telemedicine can be a safe alternative to face-to-face postoperative visits for surgical patients, streamlining recovery with no significant delays in the diagnosis of surgical complications. As healthcare systems continue to emphasize value-based care, it is important to assess whether virtual postoperative visits effectively meet patient needs while optimizing resource utilization. Patient-reported outcomes and satisfaction surveys can help identify potential gaps in care and ensure that telehealth is implemented in a way to maximize both efficiency and quality. Our primary objective is to determine whether patient satisfaction with postoperative telehealth follow-up is non-inferior to in-person clinic visits.

Participants needed: 100
Trial details
Age: 18+Biological sex: FemaleType: ObservationalSponsor: University of ChicagoUpdated: Jul 13, 2026Locations: 2Duration: 3 Months
Eligibility criteria

Participant has provided written informed consent. [+4]

Conversion to open surgery. [+3]

Status: Recruiting

Volume Support/Assist Control Mode Ventilation and Diaphragmatic Atrophy

The objective of the study is to determine how controlled mode ventilation and support mode ventilation impact ventilator-free days and diaphragmatic atrophy.

Participants needed: 468
Trial details
Age: 18+Biological sex: AllType: InterventionalSponsor: University of ChicagoUpdated: Jul 13, 2026Locations: 2
Eligibility criteria

pregnancy [+8]

Status: Recruiting

Ruxolitinib and Chemotherapy in Adolescents and Young Adults With Ph-like Acute Lymphoblastic Leukemia

This study will test if adding ruxolitinib to standard multi-drug chemotherapy regimen will be safe and tolerated in adolescents and young adults with newly diagnosed Ph-like acute lymphoblastic leukemia (ALL).

Participants needed: 15
Trial details
Phase: Phase 1Age: 18-39Biological sex: AllType: InterventionalSponsor: University of ChicagoUpdated: Jun 29, 2026Locations: 2
Eligibility criteria

Newly diagnosed de novo B-precursor acute lymphoblastic leukemia (ALL) as determ... [+17]

Patients who are receiving any other investigational agent. [+8]

Status: Recruiting

Total Intravenous Anesthesia vs Spinal Anesthesia in Patients Undergoing Unilateral Primary Total Knee Arthroplasty

The purpose of this study is to compare same-day discharge rates and recovery outcomes across an adult patient population undergoing elective Total Knee Arthroplasty (TKA), and randomized to receive either spinal block anesthesia or Total IntraVenous Anesthesia (TIVA). Primary Aim: assess same-day discharge rates between study arms (TIVA vs spinal). Secondary Aim: Postoperative comparison of recovery during PostOperative Anesthesia Care Unit (PACU) admission, diagnostic assessment scores; outcomes related to cognition, hemodynamic stability, pain, nausea and vomiting; analysis of IntraOperative electroencephalogram (EEG) monitoring metrics, e.g., total suppression time, average Bi-spectral Index monitor (BIS) value, Spectral Edge Frequency (SEF); ability for Physical Therapy (PT) evaluation prior to discharge; longterm-followup (LTFU), hospital readmission, return to surgery, etc.; adverse event (AE) monitoring.

Participants needed: 150
Trial details
Phase: Phase 1, Phase 2Age: 18+Biological sex: AllType: InterventionalSponsor: University of ChicagoUpdated: Jun 26, 2026Locations: 1
Eligibility criteria

Adults aged ≥18 years. [+6]

Age <18 years. [+9]

Status: Not yet recruiting

Effects of Stimulant Medications in PTSD

While there have been advances in understanding post-traumatic stress disorder (PTSD) as a disorder and its biological features, unfortunately only one out of five traumatized persons with PTSD reach remission after cycling through evidence-based and/or FDA-approved medications. This is especially unfortunate given that people with PTSD are often from vulnerable populations, or those whose professions entail personal sacrifice. It is clear that new serotonergic antidepressants and atypical antipsychotics will not be sufficient to fix this gap, and new mechanisms of action need to be tested. In the current proposal, the investigators test the hypothesis that mixed amphetamine salts (brand name Adderall), FDA-approved for treating attention deficit hyperactivity disorder (ADHD), can improve PTSD outcomes.

Participants needed: 40
Trial details
Phase: Phase 1Age: 18-65Biological sex: AllType: InterventionalSponsor: University of ChicagoUpdated: Jun 24, 2026Locations: 1
Eligibility criteria

Age 18 - 65 years old [+2]

Individuals with current moderate or severe substance use disorder, no past stim... [+11]

Status: Recruiting

A Study Evaluating The Combination of Immunotherapy With Radiotherapy in Non-Small Cell Lung Cancer

Current clinical trials testing the combination of immunotherapy with radiotherapy.

Participants needed: 39
Trial details
Phase: Phase 2Age: 18+Biological sex: AllType: InterventionalSponsor: University of ChicagoUpdated: Jun 16, 2026Locations: 1
Eligibility criteria

Disease-Related Criteria [+23]

Patients with history of (non-infectious) pneumonitis requiring corticosteroids. [+7]

Status: Recruiting

Lactulose to Improve Gut Health in Cancer Patients Receiving Immunotherapy

The purpose of this study is to see if lactulose can improve the effectiveness of immunotherapy in patients with advanced cancer.

Participants needed: 55
Trial details
Phase: Phase 1, Phase 2Age: 18+Biological sex: AllType: InterventionalSponsor: University of ChicagoUpdated: Jun 16, 2026Locations: 1
Eligibility criteria

Inclusion Criteria Phase I [+13]

Exclusion Criteria for Phase I [+24]

Status: Recruiting

Using Text Messages to Improve Oral Chemotherapy for Adolescents and Adults With Acute Lymphoblastic Leukemia

The purpose of this section is to learn how text message reminders might help with regularly taking chemotherapy medications for Adolescents and Adults with Acute Lymphoblastic leukemia (ALL).

Participants needed: 38
Trial details
Age: 15-39Biological sex: AllType: InterventionalSponsor: University of ChicagoUpdated: Jun 15, 2026Locations: 1
Eligibility criteria

Age of 15-39 years-old at the time of initial ALL diagnosis [+2]

Patient or caregiver who would receive text message reminders does not have a ce... [+2]

Status: Recruiting

Prostate Cancer Treatment Using Androgen Deprivation Therapy and Focal Prostate Ablation

The purpose of this research is to gather information on the safety and effectiveness of combining focal prostate ablation therapy ((aka Focal Therapy, a surgical procedure) and androgen deprivation therapy (hormone therapy).

Participants needed: 57
Trial details
Phase: Phase 2Age: 18+Biological sex: MaleType: InterventionalSponsor: University of ChicagoUpdated: Jun 16, 2026Locations: 1
Eligibility criteria

No mpMRI evidence of extra-prostatic extension (EPE) or seminal vesicle invasion... [+9]

Subject has had prior or current PCa therapies, such as biologic, chemotherapy,... [+7]

Status: Not yet recruiting

BRIDGE-US: Bridging Readiness in Deployed Neurotrauma Gaps for Excellence

The purpose of this research study is to prospectively collect biospecimens, imaging, and clinical data from patients with penetrating brain injuries across high-volume PBI sites in the US (including UChicago). Biospecimens will undergo biomarker analysis - biomarker data specific to PBI is extremely limited, and could provide critical insight to outcome identification and clinical decision making. This data will be used to build the first comprehensive PBI Data Commons, biorepository, and imaging repository which will create the infrastructure necessary to close critical knowledge gaps, advance biomarker discovery specific to PBI, and provide the foundation for future research aimed at improving prognostication and treatment for patients with this devastating injury.

Participants needed: 270
Trial details
Age: 16+Biological sex: AllType: ObservationalSponsor: University of ChicagoUpdated: Jun 9, 2026Locations: 1Duration: 7 Days
Eligibility criteria

Age: Subjects aged 16 years and older [+2]

Dead on Arrival (DOA): Patients who receive CPR with no return of pulse [+4]

Status: Not yet recruiting

Semaglutide (Wegovy) Treatment for Trichotillomania

This research study is testing the effectiveness and safety of semaglutide (Wegovy) in people with trichotillomania, also known as hair-pulling disorder.

Participants needed: 10
Trial details
Phase: Phase 2Age: 18-75Biological sex: AllType: InterventionalSponsor: University of ChicagoUpdated: Jun 10, 2026
Eligibility criteria

Men and women age 18-75; [+4]

Infrequent pulling (i.e. less than daily) or automatic pulling (i.e. no urges to... [+18]

Status: Not yet recruiting

Valbenazine in Obsessive Compulsive Disorder

The primary aim of the study is to examine the efficacy and safety of valbenazine in adults with moderate to severe obsessive-compulsive disorder (OCD).

Participants needed: 30
Trial details
Phase: Phase 2Age: 18-65Biological sex: AllType: InterventionalSponsor: University of ChicagoUpdated: Jun 10, 2026
Eligibility criteria

Men and women aged 18-65 years [+3]

Unstable medical illness based on history or clinically significant abnormalitie... [+8]

Status: Not yet recruiting

Continuous Glucose Monitoring to Detect Postpartum Dysglycemia in Patients With Gestational Diabetes

The aim of this study is to determine the ability of postpartum continuous glucose monitoring (CGM) for subjects with gestational diabetes (GDM) to predict dysglycemia on 4-12 week postpartum oral glucose tolerance test (OGTT).

Participants needed: 50
Trial details
Age: 18+Biological sex: FemaleType: InterventionalSponsor: University of ChicagoUpdated: Jun 11, 2026
Eligibility criteria

Age greater than or equal to 18 [+12]

Status: Recruiting

Phase II Study of the Effects of Laparoscopic Hyperthermic Intraperitoneal Chemotherapy (HIPEC) in Patients With Advanced Gastric Cancer

To assess if PD-L1 expression can be upregulated in peritoneal metastases from gastric cancer after the administration of HIPEC with greater frequency compared to systemic chemotherapy alone

Participants needed: 21
Trial details
Phase: Phase 2Age: 18+Biological sex: AllType: InterventionalSponsor: University of ChicagoUpdated: Jun 11, 2026Locations: 1
Eligibility criteria

Patients with histologically confirmed GC/PM only and/or positive peritoneal cyt... [+17]

Patients with coexistence of another untreated malignant neoplasm other than bas... [+7]

Status: Recruiting

A Study of the Natural Progression of Interstitial Lung Disease (ILD)

We propose to acquire data and blood samples on all patients being cared for by the Interstitial Lung Disease (ILD) program. Additionally, we will collect data and blood samples from a control group for comparator purposes. In doing so, we will be able to describe the "phenotypic" expression of these diseases.

Participants needed: 4,000
Trial details
Age: 18+Biological sex: AllType: ObservationalSponsor: University of ChicagoUpdated: Jun 9, 2026Locations: 1
Eligibility criteria

Interstitial lung disease

Does not have Interstitial lung disease

Status: Recruiting

Recovery Legal Care Clinical Trial

Hospital-Based Violence Intervention Programs (HVIPs) affiliated with trauma centers in the US often focus on individual behavior modification for reduction in re-victimization. There is a lack of reproducible evidence that has demonstrated effectiveness, given the exclusion of addressing inequities in the Social and Structural Determinants of Health (SSDOH), often the root causes of violent injury and preventable homicide. The study investigators created a Medical Legal Partnership (MLP) to partner with an existing HVIP. This novel program offers beside legal assistance to address the SSDOH. The purpose of this study is to evaluate the effectiveness of the HVIP-MLP program in improving perceived stress, violence-related outcomes, legal needs, health-related quality of life, and PTSD symptoms.

Participants needed: 500
Trial details
Age: 14+Biological sex: AllType: InterventionalSponsor: University of ChicagoUpdated: Jun 8, 2026Locations: 1
Eligibility criteria

Treatment for an interpersonal violent injury at the University of Chicago Traum... [+2]

Diagnosis of severe mental illness (e.g., psychotic disorder, schizophrenia, sui... [+7]

Status: Recruiting

AYA OMGYES Sexual Health Study

The purpose of this study is to assess the impact of the web-based intervention OMGYES.com on sexual dysfunction in young adult (YA) female-bodied cancer survivors. This pilot trial seeks to evaluate the intervention's: * feasibility * acceptability * appropriateness. Researchers will utilize an active observation period to compare outcomes between those receiving the intervention immediately and those who haven't Participants will: * Complete online modules at home * Visit the clinic every 5 weeks for questionnaires

Participants needed: 30
Trial details
Age: 18-45Biological sex: FemaleType: InterventionalSponsor: University of ChicagoUpdated: Jun 5, 2026Locations: 1
Eligibility criteria

Age 18 to 45 years [+7]

Patients receiving other investigational agents [+2]

Status: Recruiting

Achieving Routine Intervention and Screening for Emotional Health

The purpose of this project is to evaluate the effectiveness of diabetes distress screening and intervention on patients with type 2 diabetes mellitus (T2DM).

Participants needed: 1,250
Trial details
Age: 18+Biological sex: AllType: InterventionalSponsor: University of ChicagoUpdated: Jun 5, 2026Locations: 1
Eligibility criteria

Patient at a participating clinic [+3]

Pregnant

Status: Recruiting

Study of Chemotherapy-Free Induction Regimen for Ph+ Acute Lymphoblastic Leukemia With Inotuzumab Ozogamicin (InO)

This research study will add an anti-cancer drug (called inotuzumab ozogamicin also known as "InO") to treatment for participants with newly diagnosed Philadelphia chromosome-positive (Ph+) acute lymphoblastic leukemia (ALL). Doctors leading this study hope to learn if adding InO to standard induction treatment for Ph+ ALL will lead to quicker, complete molecular remission (where the disease is not detectable even with very sensitive testing techniques). The purpose of this research is to gather information regarding the effectiveness of InO in newly-diagnosed Ph+ ALL patients that have not yet received treatment.

Participants needed: 25
Trial details
Phase: Phase 2Age: 18+Biological sex: AllType: InterventionalSponsor: University of ChicagoUpdated: Jun 5, 2026Locations: 1
Eligibility criteria

Must be a newly diagnosed and untreated patient with Ph+ B-cell Acute Lymphoblas... [+7]

Isolated extramedullary disease. [+17]

Status: Recruiting

Communication Bridge 3 Study

This study will use a randomized controlled trial design to evaluate the effect of two evidence-based treatments for adults with mild-moderate Primary Progressive Aphasia (PPA). The aim of the study is to help us better understand the effects of speech-language therapy on communication abilities in individuals with PPA.

Participants needed: 200
Trial details
Phase: Phase 2Age: 18-100Biological sex: AllType: InterventionalSponsor: University of ChicagoUpdated: Jun 1, 2026Locations: 1
Eligibility criteria

Meets diagnostic criteria for PPA based on neurologist and supporting medical as... [+10]

A dementia diagnosis other than Primary Progressive Aphasia [+2]

Status: Recruiting

Hospital Implementation of a Stroke Protocol for Emergency Evaluation and Disposition

Most stroke patients are initially evaluated at the closest hospital but some need to be transferred to a hospital that can provide more advanced care. The "Door-In-Door-Out" (DIDO) process at the first hospital can take time making transferred patients no longer able to get the advanced treatments. This study will help hospitals across the US "stand up" new ways to evaluate stroke patients, decide who needs to be transferred, and transfer them quickly for advanced treatment.

Participants needed: 900
Trial details
Age: 18+Biological sex: AllType: InterventionalSponsor: University of ChicagoUpdated: May 20, 2026Locations: 8
Eligibility criteria

Age >=18 years [+1]

Final diagnosis: TIA or stroke NOS [+4]

Status: Not yet recruiting

Outpatient Visits Versus Telehealth for Postoperative Care After Minimally Invasive Gynecologic Surgery

Telehealth, or telemedicine, utilizes technology to deliver clinical care remotely, either in real time or asynchronously, between clinician and patient. Telemedicine has been successfully implemented to increase healthcare delivery for patients in rural areas with otherwise long travel times, and studies have also determined that telemedicine can increase patient satisfaction scores while simultaneously decreasing direct and indirect costs for patients. Previous scholarship has demonstrated that telemedicine can be a safe alternative to face-to-face postoperative visits for surgical patients, streamlining recovery with no significant delays in the diagnosis of surgical complications. As healthcare systems continue to emphasize value-based care, it is important to assess whether virtual postoperative visits effectively meet patient needs while optimizing resource utilization. Patient-reported outcomes and satisfaction surveys can help identify potential gaps in care and ensure that telehealth is implemented in a way to maximize both efficiency and quality. Our primary objective is to determine whether patient satisfaction with postoperative telehealth follow-up is non-inferior to in-person clinic visits.

Participants needed: 100
Trial details
Age: 18+Biological sex: FemaleType: ObservationalSponsor: University of ChicagoUpdated: May 18, 2026Locations: 2Duration: 3 Months
Eligibility criteria

Participant has provided written informed consent. [+4]

Conversion to open surgery. [+3]

Status: Recruiting

Breakthrough - T1DM and Chronic Kidney Disease

Single arm- subject treated with Tegoprubart and everolimus. The purpose of this research is to gather information on the safety and effectiveness of investigational regimen containing 2 experimental components: * An investigational drug called Tegoprubart and * Human pancreatic islet cells Both Tegoprubart and human pancreatic islet cells are considered investigational because they are not approved for use in the United States by the Food and Drug Administration (FDA). Participation in this research will last about 5 years. Assess safety, tolerability, and efficacy of transplanted islet cells and immunomodulation with Tegoprubart in combination with anti-thymocyte globulin (ATG), etanercept and with everolimus in adults with brittle T1D and chronic kidney disease (stage 2-3a).

Participants needed: 10
Trial details
Phase: Phase 1, Phase 2Age: 18-70Biological sex: AllType: InterventionalSponsor: University of ChicagoUpdated: May 18, 2026Locations: 1
Eligibility criteria

Subjects 18-70 years of age. [+12]

Body mass index (BMI) >30 kg/m2. [+25]

Status: Recruiting

Creation of a Prospective Data Collecting Registry for Genicular Artery Embolization for Arthritis

The goal of this study is to create a prospective registry (\<100 patients) to show the effectiveness of the genicular artery embolization procedure overtime in reducing bilateral or unilateral osteoarthritic knee pain as measured by Western Ontario and McMaster Universities Osteoarthritis Index (WOMAC) score.

Participants needed: 100
Trial details
Age: 18+Biological sex: AllType: ObservationalSponsor: University of ChicagoUpdated: May 13, 2026Locations: 1Duration: 1 Year
Eligibility criteria

Patients aged >=18 [+4]

Active malignancy [+12]